chronic

Dysphagia Primary Care Initial Management & Referral

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

ACG Clinical Guideline: Diagnosis and Management of Esophageal Motility Disorders 2020 · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph)

Verified against2 documents

Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph)
Dysphagia - disease-level clinical article (dysphagia-referral-clinical.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (5)

Solid-food dysphagia points toward a mechanical narrowing such as an esophageal web or ring [difficulty swallowing · stricture]
Steadily worsening dysphagia raises concern for a progressive stricture or malignancy [difficulty swallowing · stricture]
Liquid dysphagia points to a motility problem like achalasia or systemic sclerosis [difficulty swallowing]
Undigested-food regurgitation with hoarseness, bad breath, and throat fullness points to a Zenker diverticulum [diverticulosis · hoarseness · regurgitation]
A smoking or alcohol history, with or without unintended weight loss, raises suspicion for malignancy

Signs — what you find (1)

Exam may show poor dentition or gum disease, abnormal lip closure, mucosal change, or neurological signs

Tests (5)

A bedside clinical swallow evaluation is the initial test but can miss over half of significant aspiration
Videofluoroscopic swallow study visualizes bolus passage to assess swallow physiology and aspiration risk
FEES passes an endoscope through the nose to directly view the pharynx and larynx during swallowing
Barium esophagogram is a simple, low-cost first-line test for esophageal dysphagia
High-resolution manometry helps diagnose achalasia, diffuse esophageal spasm, and jackhammer esophagus

If not this — what else fits (12)

Benign esophageal stricture
Cerebrovascular accident (stroke)
Diffuse esophageal spasm
Eosinophilic esophagitis
Esophageal malignancy
Esophageal webs and rings
Gastroesophageal reflux disease (GERD)
Hiatal hernia is on the differential
Multiple sclerosis is on the differential
Parkinson disease is on the differential
Zenker diverticulum is on the differential
Dysphagia lusoria, a childhood form from vascular compression of the esophagus such as an aberrant right subclavian artery or double aortic arch

SourceStatPearls "Dysphagia" - disease-level clinical article

Presentation findings are traced to the source above.

OMEPRAZOLE

1st line

Strength20 mg

Formoral.solid

Adult dose and duration

20-40 mg once daily 30 minutes before breakfast - Until urgent endoscopic evaluation

Paediatric dose

Specialist pediatric gastroenterology referral required for paediatric dysphagia

Dose source

Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (omeprazole monograph)

Why

Empiric trial for peptic stricture / reflux dysphagia while urgent upper GI endoscopy referral is arranged

Cautions

URGENT REFERRAL MANDATORY: Dysphagia is a red-flag symptom requiring urgent upper GI endoscopy to exclude esophageal carcinoma or stricture.
Do not delay diagnostic endoscopy while prescribing PPI.
Advise soft/liquid diet and thorough chewing while awaiting evaluation.

Egyptian brands

Egyptian brand	Manufacturer	Indicative price
OMEGASTAZOLE 20MG 14 CAPS.	RIVA PHARMA S.A.E.	18.00 EGP (1.29/unit)
OMEPRAL 20MG 14 CAPS.	MEMPHIS	32.00 EGP (2.29/unit)
RISEK 20 MG 28 CAPS.	JULPHAR	75.00 EGP (2.68/unit)
OMISEC 20MG 14CAPS.	THE UNITED PHARMACEUTICALS CO LTD-JORDAN > MODERN PHARMA	42.00 EGP (3.00/unit)
EPIRAZOLE 20MG 14CAPS.	EIPICO	44.00 EGP (3.14/unit)
OMEPAK 20 MG 14 CAPS.	SEDICO	50.00 EGP (3.57/unit)
RISEK 20 MG 14 CAPS.	JULPHAR	57.00 EGP (4.07/unit)
NAPIZOLE 20MG 14 CAPS.	GLOBAL NAPI PHARMACEUTICALS	62.00 EGP (4.43/unit)

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line

Dose source

Dysphagia - disease-level clinical article (dysphagia-referral-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions

RED FLAG - Alarm features of malignancy (weight loss, bleeding, smoking/alcohol history) accompanying dysphagia require urgent head/neck or GI evaluation, not just an empiric PPI trial.
RED FLAG - Progressive (vs intermittent) dysphagia is a specific red flag suggesting stricture or malignancy rather than a benign/motility cause.
RED FLAG - Oropharyngeal dysphagia (difficulty initiating swallowing, coughing/choking, nasal regurgitation - often neurological, eg stroke) must be distinguished from esophageal dysphagia before treatment, since it carries aspiration risk and needs speech-pathology/ENT/neuro referral rather than a GI-endoscopy-linked PPI trial.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.